Market Cap : 7.44 B | Enterprise Value : 6.39 B | PE Ratio : | PB Ratio : 8.77 |
---|
NAS:IONS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IONS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Ionis Pharmaceuticals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2020 was $300.5 Mil. Ionis Pharmaceuticals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2020 was $539.1 Mil. Ionis Pharmaceuticals's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2020 was $2,389.8 Mil. Ionis Pharmaceuticals's debt to asset for the quarter that ended in Dec. 2020 was 0.35.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where Ionis Pharmaceuticals's Debt-to-Asset falls into.
Debt to Asset measures the financial leverage a company has.
Ionis Pharmaceuticals's Debt-to-Asset for the fiscal year that ended in Dec. 2020 is calculated as
Debt-to-Asset | = | Total Debt | / | Total Assets | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Total Assets | |
= | (300.462 | + | 539.112) | / | 2389.755 | |
= | 0.35 |
Ionis Pharmaceuticals's Debt-to-Asset for the quarter that ended in Dec. 2020 is calculated as
Debt-to-Asset | = | Total Debt | / | Total Assets | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Total Assets | |
= | (300.462 | + | 539.112) | / | 2389.755 | |
= | 0.35 |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.
No Headline